Pathophysiology of headache

Current Neurology and Neuroscience Reports

Volumn 3, Issue 2, 2003, Pages 109-114

  Sánchez del Río, Margarita ^a   Reuter, Uwe ^a  

^a HOSPITAL RUBER INTERNACIONAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIEMETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METOCLOPRAMIDE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROCHLORPERAZINE; SEROTONIN 3 AGONIST;

AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CLUSTER HEADACHE; DIZZINESS; GABAERGIC TRANSMISSION; GENE EXPRESSION; HEADACHE; HUMAN; NERVE CELL EXCITABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHOTOPHOBIA; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; REVIEW; SENSITIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TENSION HEADACHE; TRIGEMINUS GANGLION; VASCULAR HEADACHE; VERTIGO; VISUAL CORTEX; AUTONOMIC NEUROPATHY; BRAIN CORTEX; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MIGRAINE WITH AURA; PAIN; PATHOLOGY; PHYSIOLOGY;

AUTONOMIC NERVOUS SYSTEM DISEASES; CEREBRAL CORTEX; DIZZINESS; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; MIGRAINE WITH AURA; NITRIC OXIDE; PAIN; TOMOGRAPHY, EMISSION-COMPUTED; VERTIGO;

EID: 0037507341     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0061-6     Document Type: Review

References (51)

1. Bahra A, May A, Goadsby PJ: Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002, 58:354-361.
2. Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999, 53:537-542.
3. Peres MF, Siow HC, Rozen TD: Hemicrania continua with aura. Cephalalgia 2002, 22:246-248.
4. Milner P: Note on a possible correspondence between the scotomas of migraine and spreading depression of Leao. EEG Clin Neurophysiol 1958, 10:705.
5. Hadjikhani N, Sanchez del Rio M, Wu O, et al.: Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001, 98:4687-4692.
6. Bowyer SM, Aurora KS, Moran JE, et al.: Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 2001, 50:582-587.
7. Olesen J: Cerebral blood flow in migraine with aura. Pathol Biol (Paris) 1992, 40:318-324.
8. Olesen J, Friberg L, Olsen TS, et al.: Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990, 28:791-798.
9. Cao Y, Welch KM, Aurora S, Vikingstad EM: Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999, 56:548-554.
10. Sanchez del Rio M, Bakker D, Wu O, et al.: Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 1999, 19:701-707.
11. Wray SH, Mijovic-Prelec D, Kosslyn SM: Visual processing in migraineurs. Brain 1995, 118(Pt 1):25-35.
12. Aurora SK, Ahmad BK, Welch KM, et al.: Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology 1998, 50:1111-1114.
13. Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ: Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol 2002, 9:35-40.
14. Sanchez del Rio M, Moskowitz MA: The trigeminal system. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott Williams & Wilkins; 2000:141-149.
15. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614-624.
16. Burstein R: Deconstructing migraine headache into peripheral and central sensitization. Pain 2001, 89:107-110.
17. Strassman AM, Raymond SA, Burstein R: Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996, 384:560-564.
18. Burstein R, Yamamura H, Malick A, Strassman AM: Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998, 79:964-982.
19. Jensen K, Tuxen C, Olesen J: Pericranial muscle tenderness and pressure-pain threshold in the temporal region during common migraine. Pain 1988, 35:65-70.
20. Sandrini G, Proietti CA, Milanov I, et al.: Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett 2002, 317:135-138.
21. Samad TA, Moore KA, Sapirstein A, et al.: Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
22. Olesen J, Iversen HK, Thomsen LL: Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993, 4:1027-1030.
23. Lassen LH, Ashina M, Christiansen I, et al.: Nitric oxide synthase inhibition in migraine. Lancet 1997, 349:401-412.
24. Stepien A, Chalimoniuk M: Level of nitric oxide-dependent cGMP in patients with migraine. Cephalalgia 1998, 18:631-634.
25. Jones MG, Lever I, Bingham S, et al.: Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 2001, 21:643-655.
26. Pardutz A, Krizbai I, Multon S, et al.: Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus candalis. Neuroreport 2000, 11:3071-3075.
27. Tassorelli C, Blandini F, Costa A, et al.: Nitroglycerin-induced activation of monoaminergic transmission in the rat. Cephalalgia 2002, 22:226-232.
28. Reuter U, Bolay H, Jansen-Olesen I, et al.: Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001, 124:2490-2502.
29. Reuter U, Chiarugi A, Bolay H, Moskowitz MA: Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol 2002, 51:507-516.
30. Wei EP, Moskowitz MA, Boccalini P, Kontos HA: Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 1992, 70:1313-1319.
31. May A, Bahra A, Buchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
32. May A, Ashburner J, Buchel C, et al.: Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999, 5:836-838.
33. Weiller C, May A, Limmroth V, et al.: Brain stem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658-660.
34. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001, 41:629-637.
35. Knight YE, Bartsch T, Kaube H, Goadsby PJ: P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci 2002, 22:RC213.
36. Cao Y, Aurora SK, Nagesh V, et al.: Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 2002, 59:72-78.
37. Prado WA, Roberts MH: An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain. Brain Res 1985, 340:219-228.
38. Bolay H, Reuter U, Dunn AK, et al.: Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136-142.
39. Pappagalo M, Szabo Z, Esposito G, et al.: Imaging neurogenic inflammation in patients with migraine headaches. Neurology 1999, 52:A274-A275.
40. Gebel H, Czech N, Heinze-Kuhn K, et al.: Evidence of regional protein plasma extravasation in cluster headache using Tc-99m albumin SPECT [abstract]. Cephalalgia 2000, 20:287.
41. Lee TG, Choi WS, Chung KC: Ophthalmoplegic migraine with reversible enhancement of intraparenchymal abducens nerve on MRI. Headache 2002, 42:140-141.
42. Coleston DM, Chronicle E, Ruddock KH, Kennard C: Precortical dysfunction of spatial and temporal visual processing in migraine. J Neurol Neurosurg Psychiatry 1994, 57:1208-1211.
43. Cady RK, Sheftell F, Lipton RB, et al.: Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000, 22:1035-1048.
44. Neuhauser H, Leopold M, von Brevern M, et al.: The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001, 56:436-441.
45. Baloh RW: Neurotology of migraine. Headache 1997, 37:615-621.
46. Haan J, Terwindt GM, Ophoff RA, et al.: Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia 1995, 15:477-481.
47. Vass Z, Steyger PS, Hordichok AJ, et al.: Capsaicin stimulation of the cochlea and electric stimulation of the trigeminal ganglion mediate vascular permeability in cochlear and vertebro-basilar arteries: a potential cause of inner ear dysfunction in headache. Neuroscience 2001, 103:189-201.
48. Tek DS, McClellan DS, Olshaker JS, et al.: A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990, 19:1083-1087.
49. Ladabaum U, Hasler WL: Novel approaches to the treatment of nausea and vomiting. Dig Dis 1999, 17:125-132.
50. Barbanti P, Fabbrini G, Pesare M, et al.: Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002, 22:256-259.
51. Iadecola C: From CSD to headache: a long and winding road. Nat Med 2002, 8:110-112.